Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Stockholders' Equity (Deficit)

v3.21.1
Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Series A Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Subscriptions Receivable [Member]
Subscriptions Payable [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2018 $ 34,292 $ 1,278,352 $ (602) $ (4,090) $ (1,959,982) $ (101) $ (652,131)
Balance, shares at Dec. 31, 2018 34,291,905              
Cash received on subscriptions receivable 602 602
Common stock sold for cash $ 8,260 4,122,090 250,000 4,380,350
Common stock sold for cash, shares 8,260,700              
Common stock sold to CEO, debt cancelled in lieu of cash payment $ 400 199,600 200,000
Common stock sold to CEO, debt cancelled in lieu of cash payment, shares 400,000              
Cashless exercise of common stock options $ 51 (51)
Cashless exercise of common stock options, shares 51,040              
Common stock issued on debt conversions $ 1,253 500,144 501,397
Common stock issued on debt conversions, shares 1,253,493              
Common stock issued for services $ 100 236,460 236,560
Common stock issued for services, shares 99,666              
Amortization of common stock options issued for services 1,402,635 1,402,635
Amortization of common stock options issued for services, OWP Ventures, Inc. 88,297 88,297
Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1) $ 1,323 (10,730) 101 (9,306)
Exchange of OWP Ventures, Inc. shares for One World Pharma, Inc. shares (1:1), shares 1,322,501              
Common stock cancelled pursuant to merger with OWP Ventures, Inc. $ (875) 875
Common stock cancelled pursuant to merger with OWP Ventures, Inc., shares (875,000)              
Beneficial conversion feature on convertible note 332,332 332,332
Loss on foreign currency translation (12,158) (12,158)
Net loss (6,207,184) (6,207,184)
Balance at Dec. 31, 2019 $ 44,804 8,150,004 250,000 (16,248) (8,167,166) 261,394
Balance, shares at Dec. 31, 2019 44,804,305              
Common stock sold for cash $ 500 249,500 (175,000) 75,000
Common stock sold for cash, shares 500,000              
Common stock issued for services $ 7,781 3,570,719 3,578,500
Common stock issued for services, shares 7,781,000              
Amortization of common stock options issued for services 2,170,685 2,170,685
Loss on foreign currency translation (36,622) (36,622)
Preferred stock units sold for cash $ 1,502,330
Preferred stock units sold for cash, shares 150,233                
Series A convertible preferred stock declared ($0.60 per share) (37,236) (37,236)
Net loss (7,965,160) (7,965,160)
Balance at Dec. 31, 2020 $ 1,502,330 $ 53,085 $ 14,103,672 $ 75,000 $ (52,870) $ (16,132,326) $ (1,953,439)
Balance, shares at Dec. 31, 2020 150,233 53,085,305